Printer Friendly

A new pocket-sized device may allow doctors to check a woman's breast-cancer risk in minutes with just droplets of blood or a sliver of breast tissue, Canadian researchers reported.

They said the microchip device can measure levels of the hormone estrogen using far smaller samples than conventional methods, making it possible to quickly screen for breast cancer risk or check to see if breast cancer treatments are working. "The new device is compatible with extremely small samples--around 1,000 times smaller than the amount needed for conventional analyses," said Aaron Wheeler of the University of Toronto, whose study appears in the journal Science Translational Medicine. "We could replace the invasive techniques of intravenous blood collection and even tissue biopsies with pinpricks of blood, or fine needle aspirates of tissue," Wheeler said. The experimental device advances the notion of a so-called "lab on a chip"--a device that shrinks down several lab functions onto a microchip. Wheeler said other such tools rely on microchannels--a series of interconnected, enclosed tubes--but these cannot process tissue because they can clog up.

"The method we're reporting here relies on digital microfluid moved across an open surface. Droplets essentially can be made to dance across the surface," Wheeler said. "There are no tubes to clog."
COPYRIGHT 2009 MedContent Media, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2009 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:RESEARCH & TECHNOLOGY
Publication:MondayMorning
Article Type:Brief article
Geographic Code:1USA
Date:Oct 12, 2009
Words:180
Previous Article:Teva Pharmaceutical Industries Ltd.
Next Article:Three American scientists won the Nobel Prize in medicine for research on cell division and the "immortality enzyme" that can help cells multiply...
Topics:

Terms of use | Privacy policy | Copyright © 2021 Farlex, Inc. | Feedback | For webmasters